Pharmaceuticals, Biotechnology and Life Sciences
OXNARD, Calif.–(BUSINESS WIRE)–$CURR #CBD—CURE Pharmaceutical Holdings (“CURE” or the “Company”) (OTC: CURR), a holding company focused on the innovation of…
BEVERLY HILLS, Calif.–(BUSINESS WIRE)–GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA) an immuno-oncology company focused on innovative therapies based on the Company’s…
BEVERLY HILLS, Calif.–(BUSINESS WIRE)–GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA) an immuno-oncology company focused on innovative therapies based on the Company’s…
Findings from Phase 1b RAMP clinical trial lay the groundwork for Phase 3 CASPAR clinical trial evaluating Rubraca® (rucaparib) and…
BEVERLY HILLS, Calif.–(BUSINESS WIRE)–GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA) an immuno-oncology company focused on innovative therapies based on the Company’s…
IQVIA OCE sees rapid growth, including expanded global OCE rollout by a top-10 pharma company DANBURY, Conn. & RESEARCH TRIANGLE…
Financing to advance two clinical programs and accelerate discovery efforts SAN DIEGO–(BUSINESS WIRE)–Pipeline Therapeutics, a biopharmaceutical company focused on the…
− Achieved Fourth Quarter and Full Year 2020 Global Net Product Revenues of $113 Million and $362 Million, Respectively –…
IQVIA OCE sees rapid growth, including expanded global OCE rollout by a top-10 pharma company DANBURY, Conn. & RESEARCH TRIANGLE…
Partnerships with Flatiron Health and Foundation Medicine to accelerate R&D efforts and aid in design of clinical trials CAMBRIDGE, Mass.–(BUSINESS…